Antineoplastic agents. Part 409: Isolation and structure of montanastatin from a terrestrial actinomycete

Bioorganic and Medicinal Chemistry

Volumn 7, Issue 5, 1999, Pages 895-899

  Pettit, George R ^a   Tan, Rui ^a   Melody, Noeleen ^a   Kielty, Joshua M ^a   Pettit, Robin K ^a   Herald, Delbert L ^a   Tucker, Bruce E ^a   Mallavia, Louis P ^b   Doubek, Dennis L ^a   Schmidt, Jean M ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Actinomycete; Anticancer; Antimicrobial; Montanastatin; Valinomycin

Indexed keywords

ANTINEOPLASTIC AGENT; DEPSIPEPTIDE; MONTANASTATIN; UNCLASSIFIED DRUG; VALINOMYCIN;

ACTINOBACTERIA; ANIMAL CELL; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; CONTROLLED STUDY; DRUG ISOLATION; DRUG STRUCTURE; GROWTH INHIBITION; HUMAN CELL; LEUKEMIA CELL; MASS SPECTROMETRY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SHORT SURVEY; STREPTOMYCES;

ACTINOBACTERIA (CLASS); ANIMALIA; FUNGI; STREPTOMYCES ANULATUS; STREPTOMYCES EXFOLIATUS; UNCULTURED ACTINOMYCETE;

EID: 0033135623     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(99)00024-3     Document Type: Article

References (20)

1. For contribution 408 refer to: Smith III, A. B.; Lin, Q.; Pettit, G. R.; Chapuis, J -C.; Schmidt, J. M. Bioorg. Med Chem. Lett. 1998, 8, 567.
2. (a) Zhang, H.-P.; Kakeya, H.; Osada, H. Tetrahedron Lett. 1997, 38, 1789.
3. (b) Ryoo, I.-J.; Song, K.-S.; Kim, J.-P.; Kim, W.-G.; Koshino, H.; Yoo, I.-D. J. Antibiotics 1997, 50, 256.
4. (c) Leet, J. E.; Schroeder, D. R.; Golik, J.; Matson, J. A.; Doyle, T. W.; Lam, K. S.; Hill, S. E.; Lee, M. S.; Whitney, J. L.; Krishnan, B. S. J. Antibiotics 1996, 49, 299.
5. (d) Xing-Wang, W.; Bin, X. Med. Chem. Res. 1996, 225.
6. (e) Kajimura, Y.; Kaneda, M. J. Antibiotics 1997, 50, 220.
7. (f) Shibazaki, M.; Sugawara, T.; Nagai, K.; Shimizu, Y.; Yamaguchi, H.; Suzuki, K. J. Antibiotics 1996, 49, 340.
8. (a) Brockmaann, H.; Schmidt-Kastener, G. Chem. Ber. 1955, 88, 57.
9. (b) Shemyakin, M. M.; Aldanova, N. A.; Vinogradova, E. I.; Feigina, M. Y. Tetrahedron Lett. 1963, 351.
10. (c) Shemyakin, M. M.; Aldanova, N. A.; Vinogradova, E. I.; Feigina, M. Y. Tetrahedron Lett. 1963, 1921.
11. (d) Rapaport, H.; Kuzmenka, I.; Kjaer, K.; Howes, P.; Bouwman, W.; Als-Nielsen, J.; Leiserowitz, L.; Lahav, M. J. Am. Chem. Soc. 1997, 119, 11211.
12. (a) Karle, I. L. J. Am. Chem. Soc. 1975, 97, 4379.
13. (b) Smith, G. D.; Duax, W. L.; Langs, D. A.; Detitta, G. T.; Edmonds, J. W.; Rohrer, D. C.; Weeks, C. M. J. Am. Chem. Soc. 1975, 97, 7442.
14. (c) Unpublished results, D. L. Herald, Cancer Research Institute, Arizona State University, 1993. Experimental details and fractional atomic coordinates available on request.
15. National Committee for Clinical Laboratory Standards. 1997. Performance standards for antimicrobial disk susceptibility tests - sixth edition; Approved standard M2-A6. NCCLS, Wayne, PA.
16. Robbins, P. W.; Hubbard, S. C.; Turco, S. J.; Wirth, D. F. Cell 1977, 12, 893.
17. Alonso-Caplen, F. V.; Compans, R. W. J. Cell Biology 1983, 97, 659.
18. Zilberstein, A.; Snider, M. D.; Port, M. Lodish, H. F. Cell 1980, 21, 417.
19. Westall, F.; Hesser, H. Analytical Biochemistry 1974, 61, 610.
20. Shaw, C. J.; Cotter, M. L. Chromatographia 1986, 21, 197.